This test is most useful if any of these apply to you.
If you or your child has ever reacted to peanut, been told to avoid it based on a positive allergy test, or had a vague sense of peanut sensitivity, this is one of the most useful blood tests to help settle the question. It can help distinguish between a true peanut allergy that could cause a serious reaction and harmless sensitization that often gets mistaken for allergy on standard tests.
The test measures an antibody (called IgE) that your immune system has built specifically against Ara h 2, the main allergy-triggering protein inside a peanut. A clear result here can help confirm an allergy, reduce unnecessary food avoidance, and reduce the need for a supervised oral food challenge, which is the older way of proving peanut allergy.
Peanut is not one protein but a mix of several. The protein called Ara h 2 (short for the second allergen identified in Arachis hypogaea, the peanut plant) is the one most strongly tied to real, clinically dangerous peanut allergy. Standard peanut allergy blood tests measure antibodies against the whole peanut, which lumps together harmless and dangerous proteins. This test isolates the antibodies against Ara h 2 alone.
Those antibodies are made by specialized immune cells, many of which sit in the lining of the stomach and gut. When you eat peanut, the antibodies signal mast cells and basophils (immune cells that release allergy chemicals) to release the chemicals that cause hives, swelling, vomiting, breathing trouble, or anaphylaxis. Higher Ara h 2 IgE (immunoglobulin E, the antibody class tied to allergic reactions) generally means more of those antibodies are present and the immune machinery is primed for a reaction.
A standard whole-peanut IgE blood test or skin prick test picks up everyone whose immune system has noticed peanut, including many people who can eat it without trouble. That is the source of many wrongly diagnosed peanut allergies and unnecessary lifelong avoidance. Ara h 2 testing cuts through that noise.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| 321 high-risk infants who had not yet eaten peanut | Ara h 2 IgE versus whole-peanut IgE and skin prick test | Ara h 2 IgE outperformed whole-peanut IgE and skin prick testing for distinguishing true peanut allergy from tolerance |
| 100 UK children evaluated for peanut allergy | Ara h 2 IgE versus whole-peanut IgE | Ara h 2 IgE provided higher diagnostic accuracy than whole-peanut IgE for peanut allergy |
| Korean children evaluated for peanut allergy | Ara h 2 IgE thresholds for predicting allergy | At a higher Ara h 2 level, every positive result meant true allergy (100% positive predictive value) |
Source: Keet et al. 2021 (high-risk infants); Hemmings et al. 2020 (UK children); Kim et al. 2015 (Korean children).
What this means for you: if a basic peanut allergy panel comes back positive but the clinical history is murky, asking specifically for Ara h 2 IgE before committing to lifelong avoidance is worth the extra step. A meta-analysis pooling many of these studies found that antibodies against Ara h 2 are roughly as good as detailed clinical prediction models that combine skin tests, total IgE, and history.
Higher Ara h 2 IgE tracks with true, food-challenge-confirmed peanut allergy across studies in infants, children, and adults. It is also one of the better blood predictors of more severe reactions and reactions to small amounts of peanut, although it is not perfect at predicting severity on its own.
In a double-blind placebo-controlled study of 102 people, antibody levels against Ara h 2 (along with a related protein called Ara h 6) were the best blood markers for picking out those at risk of moderate-to-severe peanut reactions. Other peanut components like Ara h 1, Ara h 3, Ara h 8, and Ara h 9 generally fail to distinguish true allergy from harmless sensitization.
A single Ara h 2 IgE result tells you where you are today. Tracking it over time tells you where you are headed, and that is where the test becomes genuinely valuable for anyone managing or trying to outgrow peanut allergy.
In a longitudinal study of 156 children, falling Ara h 2 IgE levels (often paired with rising peanut-specific IgG, a different antibody type that blocks allergic reactions) were linked to natural resolution of peanut allergy, with about one in three infants outgrowing it by age 10. The same pattern, falling Ara h 2 IgE and rising IgG4, also tracks with successful peanut oral immunotherapy. If you or your child is undergoing oral immunotherapy or watching for natural resolution, the only way to see this shift is repeat testing.
A reasonable cadence: get a baseline test if peanut allergy is suspected or known, repeat in 6 to 12 months if levels are dropping or you are trying immunotherapy, and at least annually if you are watching for resolution in a child.
Ara h 2 IgE is one of the more stable allergy blood markers, but a few things can still cause confusion when interpreting a single value.
If your Ara h 2 IgE is clearly elevated and you have a history of peanut reactions, the diagnosis is essentially confirmed: strict avoidance and an epinephrine auto-injector should be in place. If the result is high but you have never knowingly reacted, an allergist visit is the right next step before either eating peanut or committing to avoidance. If the result is undetectable but you have had reactions to peanut-containing foods, consider that something else in the food (other tree nuts, sesame, or another allergen) may be the real trigger, and broader component or skin testing is warranted.
For borderline results, a basophil activation test or supervised oral food challenge with an allergist remains the most definitive next step. Skin prick testing and whole-peanut IgE are useful companion tests that, together with Ara h 2, build a clearer picture than any one test alone.
Evidence-backed interventions that affect your Peanut (Ara h 2) IgE level
Peanut (Ara h 2) IgE is best interpreted alongside these tests.